猫头油:一种潜在的辅助治疗炎症性肠道疾病?
Sisanda Nomcebo Mhlanga1,2, Gordon Stanley Howarth1,2,3, Suzanne Mashtoub1,2,4,5,6
1School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Inflammatory intestinal diseases
|January 19, 2026
概括
由于其在临床前研究中观察到的抗炎性质,油显示出治疗炎症性肠病 (IBD) 的潜力. 需要进一步的临床试验来确认其作为IBD补充疗法的安全性和有效性.
科学领域:
- 胃肠病学 胃肠病学
- 自然产品研究自然产品研究
- 炎症生物学 炎症生物学
背景情况:
- 炎症性肠病 (IBD),包括克罗恩氏病和性结肠炎,是一种慢性疾病,治疗疗效有限,副作用很大.
- 目前IBD的治疗选择包括一系列药物和手术,但复发仍然是许多患者的担忧.
研究的目的:
- 探索天然产品埃穆油 (EO) 的潜力,作为炎症性肠病 (IBD) 的辅助疗法.
- 根据临床前证据,审查油的抗炎,抗氧化和组织愈合特性.
主要方法:
- 这是对口服驼油 (EO) 现有临床前研究的叙述性综述.
- 这篇综述重点关注驼油的成分及其在肠道炎症动物模型中证明的影响.
主要成果:
- 临床前试验表明,驼油具有有益于肠道愈合的抗炎,抗氧化和修复性质.
- 在动物模型中,口服母油已显示在各种肠道炎症疾病中减少炎症和粘膜损伤.
结论:
- 基于临床前数据,油对治疗炎症性肠病 (IBD) 具有有希望的特性.
- 进一步严格的临床试验至关重要,以确定驼油作为IBD补充治疗的安全性和有效性.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
971
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
971
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
908
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
908
01:21Inflammatory Bowel Disease V: Surgical Management
458
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
458
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
48.6K
DNBS/TNBS induced colitis offers an alternative and inexpensive method to study the pathobiology of inflammatory bowel disease. The protocol discussed in this paper outlines the successful application of DNBS to induce colitis in mice and rats and allows one to thoroughly study host-mediated intestinal...
48.6K
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
8.1K
Dynamic adhesion of immune cells to the vessel wall is a prerequisite for gut homing. Here, we present a protocol for a functional in vitro assay for the impact analysis of anti-integrin antibodies, chemokines or other factors on the dynamic cell adhesion of human cells using addressin-coated...
8.1K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
532
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
532